NCT06907667Recruiting
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure - CHRONOVAX 2
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
Immune response to influenza vaccine in patients with chronic renal insufficiency.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 735 (estimated)
- First submitted
- 26 Mar 2025
- Start date
- 3 Sept 2025
- Primary completion date
- Mar 2027
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Diseases
- Chronic kidney disease
- NCT number
- NCT06907667
What you commit to
- Study type: Interventional
- Planned participants: 735
- From 3 Sept 2025 to the primary completion date, Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous influenza vaccination for the current season;
- Treatments with a major impact on vaccine response:
- Treatment of rejection within the previous 3 months;
- Renal transplantation with induction performed within the previous 6 months;
- Immunosuppressive treatment including CTLA4 agonist, complement inhibitor, anti-CD20;
Other illness
- Known hypersensitivity to influenza vaccine or egg proteins;
- Current infection;
- Current acute illness;
Other
- Treatments that may distort the serological response: Polyvalent immunoglobulin infusion within the preceding 3 months;
- Vulnerable persons (minors, adults under guardianship or trusteeship, persons deprived of their liberty, persons unable to speak French);
- Subjects not affiliated to Social Security.
Who the study is looking for
- Chronic renal failure patient at stage 4 or 5 (i.e. estimated GFR \< 30mL/min/1.73m2); or Dialysis patient; or renal transplant patient regardless of GFR;
- Age ≥ 18 years;
- Indication for influenza vaccination;
- Express free and informed consent.
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Nice - Hôpital Pasteur 2 Coordinator of this site? Confirm its status | Nice | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.